Parkinson's Disease
News, opinions and meeting coverage in neurology.
<ѻýҕl>Droxidopa for OH Slammed by FDA Reviewersѻýҕl>
SILVER SPRING, Md. -- Droxidopa (Northera) is getting a second look by an FDA advisory committee for the treatment of orthostatic hypotension stemming from neurological disorders like Parkinson's disease, but an agency review doesn't look promising for approval.
Jan 13, 2014
<ѻýҕl>Parkinson's Drug Doesn't Slow Disease Progress, FDA Staff Saysѻýҕl>
WASHINGTON -- Azilect (rasagiline), which is already approved to treat symptoms of Parkinson's disease, does not appear effective at slowing progression of the neurodegenerative disease, according to an FDA review.
Oct 14, 2011
<ѻýҕl>FDA Blocks Sale of Supplements for Parkinson's and Alzheimer'sѻýҕl>
WASHINGTON -- The FDA filed a permanent injunction against two Minnesota companies that distributed amino acid products marketed as treatments for Parkinson's disease, Alzheimer's disease, and a number of other neurological disorders.
Sep 16, 2011